Corium Inc.
  • Who We Are
    • About Us
    • Leadership
    • Board of Directors
    • Our Mission & Values
  • What We Do
    • Our Products & Pipeline
    • Partnering
    • Our Proprietary Platforms
  • News & Media
  • Join Us
  • Contact Us
  • Who We Are
    • About Us
    • Leadership
    • Board of Directors
    • Our Mission & Values
  • What We Do
    • Our Products & Pipeline
    • Partnering
    • Our Proprietary Platforms
  • News & Media
  • Join Us
  • Contact Us

News & Media

March 1, 2018

By coriumi1-ca -

Corium Prices Offering of $100 Million of 5% Convertible Senior Notes
MENLO PARK, Calif. , March 01, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the pricing of its offering of $100,000,000…

February 28, 2018

By coriumi1-ca -

Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes; Receives FDA Feedback on Pilot Bioequivalence Study
MENLO PARK, Calif. , Feb. 28, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that it intends to offer, subject to market…

February 8, 2018

By coriumi1-ca -

Corium Reports First Quarter Fiscal 2018 Finaical Results and Corporate Highlights
MENLO PARK, Calif. , Feb. 08, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results for the first…

February 6, 2018

By coriumi1-ca -

Corium to Present at Upcoming Healthcare Investor Conferences
MENLO PARK, Calif. , Feb. 06, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that the company will be participating in…

February 1, 2018

By coriumi1-ca -

Corium to report First Quarter Fiscal 2018 Financial Results on Thursday, February 8, 2018
MENLO PARK, Calif. , Feb. 01, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the first quarter ended December 31, 2017 on February 8, 2018 after the close of the U.S. financial markets. Corium will host a conference call…

Page 4 of 21«‹23456›»
See all News

News Archive

  • Home
  • Who We Are
  • What We Do
  • News & Media
  • Join Us
  • Contact Us
  • Terms of Use
  • Privacy Policy








© 2020 Corium Inc. All rights reserved.